Drug Profile
AG B1511
Alternative Names: AG-B1511Latest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Biobetters
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Immunological disorders
Most Recent Events
- 01 Nov 2021 Preclinical trials in Immunological disorders in South Korea (Parenteral) (Ahn-Gook Pharmaceutical pipeline, November 2021)
- 28 Sep 2021 No recent reports of development identified for research development in Immunological-disorders in South Korea
- 22 Aug 2017 Early research in Immunological disorders in South Korea (unspecified route)